ARBIOS TECHNOLOGIES, INC.
ARBIOS developed a novel hybrid bioartificial live r(HyBAL) to treat patients with liver failure of various etiologies. In the absence of any other alternative, such patients must receive a liver tran ...SBIR Phase I 2002 Department of Health and Human Services
DESCRIPTION (provided by applicant): ARBIOS developed a novel liver support therapy (SEPET) to treat patients with severe acute liver failure (ALF). In the absence of any other alternative, such patie ...SBIR Phase I 2003 Department of Health and Human Services